Ironwood Pharmaceuticals, Inc. (IRWD)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Ironwood Pharmaceuticals, Inc. (IRWD) is down 2.7% since the beginning of the year. At $3 per share, IRWD is trading 43.3% below its 52-week high of $6. Investors who bought $1,000 worth of IRWD shares 5 years ago would now be looking at an investment worth $274.

Ironwood Pharmaceuticals, Inc. (IRWD) has returned -2.67% so far this year and 427.33% over the past 12 months. Over the last ten years, IRWD has returned -12.83% per year, falling short of the S&P 500 Index benchmark, which averaged 13.75% annually.

Based on dividend-adjusted daily data since Feb 3, 2010, IRWD's average daily return is +0.03%, while the average monthly return is +0.56%. At this rate, an investment would double in approximately 10.3 years.

Historically, 46% of months were positive and 54% were negative. The best month was Nov 2025 with a return of +82.3%, while the worst month was Jan 2025 at -47.2%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 5 months.

On a daily basis, IRWD closed higher 49% of trading days. The best single day was Jun 10, 2025 with a return of +36.3%, while the worst single day was Jan 30, 2025 at -38.2%.

Ironwood Pharmaceuticals, Inc. has an annualized alpha of -4.90%, beta of 0.98, and R2 of 0.09 versus S&P 500 Index. Calculated based on daily prices since February 04, 2010.

• This stock participated in 158.67% of S&P 500 Index downside but only 69.00% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.09 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

IRWD ranks 95 for risk / return — in the top 95% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The table below present risk-adjusted performance metrics for Ironwood Pharmaceuticals, Inc. (IRWD) and compare them to S&P 500 Index.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Ironwood Pharmaceuticals, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Ironwood Pharmaceuticals, Inc. was 97.31%, occurring on May 23, 2025. The portfolio has not yet recovered.

The current Ironwood Pharmaceuticals, Inc. drawdown is 84.43%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Ironwood Pharmaceuticals, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Ironwood Pharmaceuticals, Inc. is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.